| | 50-48-6 Basic information More.. |
| Product Name: | Amitriptyline | | Synonyms: | 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene;5-(3'-Dimethylaminopropylidene)-dibenzo-(a,d)(1,4)-cycloheptadiene;5-(3-Dimethylpropylidene)dibenzo(a,d)(1,4)cycloheptadiene;5-(gamma-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene;5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,d)-10,11-dihydrocycloheptene;5-(gamma-Dimethylaminopropylidene)-5H-Dibenzo[a,d][1,4]cycloheptadiene;5-(gamma-Dimethylaminopropylidine)-5H-dibenzo(a,d)(1,4)cycloheptadiene;3-(10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-ylidene)-n,n-dimethyl-1-propan | | CAS: | 50-48-6 | | MF: | C20H23N | | MW: | 277.4 | | EINECS: | 200-041-6 | | Mol File: | 50-48-6.mol |  |
Use
Amitriptyline, a tricyclic antidepressant was introduced in 1961
for the management of endogenous depression and is listed in the 8th WHO Model
List of Essential Drugs. Much of the adverse effects are caused by its
antimuscarinic actions. These include dry mouth, cardiac arrhythmias, central
nervous system disturbances, blood disorders and risk of suicide. The risk of
suicide and dangers related to overdosage led the Norwegian Medicines Control
Authority to put the higher strength formulation under prescribing restriction in
1992. The risk of death following overdosage is apparently higher for products
containing tricyclic compounds as compared with nontricyclic products.
- Amitriptyline
-
- US $39.00-91.00 / mg
- 2024-11-19
- CAS:50-48-6
- Min. Order:
- Purity: 99.64%
- Supply Ability: 10g
- Amitriptyline
-
- US $0.00-0.00 / g
- 2023-09-14
- CAS:50-48-6
- Min. Order: 100g
- Purity: 99%
- Supply Ability: 20 tons
- Amitriptyline
-
- US $30.00 / kg
- 2023-09-07
- CAS:50-48-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000t/year
|
|
50-48-6
Recommend Suppliers |
|